April 21, 2026
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreApril 21, 2026
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreApril 21, 2026
According to market estimations the nerve conduit sector size to capture US$ 176.73 mn in 2025 and is to soar US$ 289.84 mn by 2030. The nerve conduit market is expanding due to the rising prevalence of peripheral nerve injuries, driven by an increase in surgeries and trauma cases. Nerve conduits, which guide axonal regrowth, are made from syntheti...
April 21, 2026
According to market estimations, the knee replacement prosthesis market is projected to grow from US$ 13.57 bn in 2025 is to witness US$ 18.07 bn by 2030. The demand for knee replacement prostheses is increasing globally due to the rise in the elderly population. The age group is more prone to knee-related issues and requires knee replacement to ga...
April 21, 2026
According to market estimations the global leuprorelin drugs market, valued at US$ 2.60 billion in 2023, is projected to reach US$ 4.78 billion by 2034, driven by rising cancer cases and gender-affirming surgeries. North America leads the market, while Asia-Pacific shows the fastest growth....
April 21, 2026
According to market reasearchers, the global nerve conduits, wraps, protectors, cap, and connectors market is projected to reach US$ 691.98 million by 2034, driven by rising diabetes cases, demand for minimally invasive surgeries, and advancements in nerve repair technologies across North America and Asia-Pacific....
April 21, 2026
According to market estimations, the clavulanic acid series API market, valued at US$ 385 million in 2023, is projected to reach US$ 777.66 million by 2034, driven by rising antibiotic resistance and R&D. North America leads, Asia-Pacific grows fastest, with potassium clavulanate and oral meds dominating....
April 21, 2026
According to research analysis, the global Factor Xa inhibitors market, valued at US$ 22.1 billion in 2023, is projected to reach US$ 41.52 billion by 2034, driven by rising cardiovascular diseases. North America leads, while Asia-Pacific shows fastest growth. Key players include Pfizer, Bayer, and AstraZeneca....
April 21, 2026
According to market projections, the blood plasma fractionation sector is expected to grow from USD 33.52 billion in 2024 to USD 74.74 billion by 2034, reflecting a CAGR of 8.35%. The rising incidences of immunological disorders and the prevalence of rare chronic disorders, increasing awareness about blood donations, and growing research and develo...
April 21, 2026
According to market projections, the global direct oral anticoagulants (DOACs) market is projected to reach US$ 102.36 billion by 2034, growing at a CAGR of 8%. Growth is driven by rising cardiovascular cases, preference for oral Factor Xa inhibitors, and expanding R&D in safer, AI-powered treatments....
April 21, 2026
According to market estimations the global medical device gaskets & seals sector is projected to grow from USD 0.92 billion in 2023 to USD 1.57 billion by 2034 at a 5% CAGR. Growth is driven by medical innovations, rising surgeries, 3D printing, and chronic disease prevalence, with strong demand in Asia-Pacific....
April 21, 2026
According the research analysis, the global blood plasma freezer market, valued at US$ 542 million in 2023, is projected to reach US$ 903.01 million by 2034. The demand for blood plasma freezer is increasing globally to maintain the freezing temperature of fresh frozen plasma, red blood cells, platelet concentrates and cryoprecipitate for safe stor...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com